Entera Bio Ltd. Quarterly Operating Income (Loss) in USD from Q1 2021 to Q4 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Entera Bio Ltd. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2021 to Q4 2024.
- Entera Bio Ltd. Operating Income (Loss) for the quarter ending December 31, 2024 was -$2.34M, a 19.1% decline year-over-year.
- Entera Bio Ltd. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$9.59M, a 7.81% decline year-over-year.
- Entera Bio Ltd. annual Operating Income (Loss) for 2024 was -$9.59M, a 7.81% decline from 2023.
- Entera Bio Ltd. annual Operating Income (Loss) for 2023 was -$8.89M, a 31.7% increase from 2022.
- Entera Bio Ltd. annual Operating Income (Loss) for 2022 was -$13M, a 6.55% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)